未登录

M

Michael Lang

mcgill university

H指数:16

被引数:881

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Does an App a Day Keep the Doctor Away? AI Symptom Checker Applications, Entrenched Bias, and Professional Responsibility

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2024-06-051

OA

Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian context

癌症风险预测的监管：加拿大背景下的法律考量与利益相关者视角

IF3.6

2023-06-261

OAAI

Military occupation and testicular germ cell tumour risk among US Air Force servicemen

美国空军军人的军事占领和睾丸生殖细胞肿瘤风险

OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

IF3.1

2023-03-275

OA

Returning individual research results in international direct-to-participant genomic research: results from a 31-country study

EUROPEAN JOURNAL OF HUMAN GENETICS

IF4.6

2022-04-283

OAAI

Artificial Intelligence in Cardiovascular Imaging: Unexplainable Legal and Ethical Challenges?

CANADIAN JOURNAL OF CARDIOLOGY

IF5.3

2022-02-0122

PRE

Legal and Ethical Considerations for the Design and Use of Web Portals for Researchers, Clinicians, and Patients: Scoping Literature Review

为研究人员，临床医生和患者设计和使用门户网站的法律和伦理考虑: 范围文献综述

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2021-11-116

OA

Trends in cancer imaging by indication, care setting, and hospital type during the COVID-19 pandemic and recovery

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

What's in the Box?: Uncertain Accountability of Machine Learning Applications in Healthcare

AMERICAN JOURNAL OF BIOETHICS

IF20.8

2020-10-269

PREAI

Mind the App: Considerations for the Future of Mobile Health in Canada

JMIR MHEALTH AND UHEALTH

IF6.2

2019-11-047

OAAI

Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2019-05-0129

OAAI

PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit

NEUROLOGY AND THERAPY

IF4.8

2019-03-268

OAAI

A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity

基于Delphi的关于肉毒杆菌毒素抗凝治疗肢体痉挛的共识声明

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

IF3.7

2018-11-019

PREAI

Boulias, Chris; Ismail, Farooq; Phadke, Chetan P.; Bagg, Stephen; Bureau, Isabelle; Charest, Stephane; Chen, Robert; Cheng, Albert; Ethans, Karen; Fink, Milo; Finlayson, Heather; Gulasingam, Sivakumar; Guo, Meiqi; Haziza, Muriel.; Hosseini, Hossein; Khan, Omar; Lang, Michael.; Lapp, Timothy; Leckey, Robert; Shan, Rodney Li Pi; Liem, Nathania; Lo, Alexander; Mason, Mark; McNeil, Stephen; McVeigh, Sonja; Miller, Thomas; Mills, Patricia B.; Naud, Pierre; O'Connell, Colleen; Petitclerc, Marc; Prevost, Julie; Reebye, Rajiv; Richardson, Denyse; Satkunam, Lalith; Sharma, Satyendra; Short, Christine; Sirois, Genevieve; Unarket, Milan; Wein, Theodore; Wilkins, Kathryn; Winston, Paul

The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study

JOURNAL OF NEUROLOGY

IF4.6

2018-08-3142

PREAI

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

NEUROTHERAPEUTICS

IF6.9

2018-01-0111

OAAI

Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study

IF3.4

2017-02-0118

PREAI

36 MONTHS PANGAEA: A 5-YEAR NON-INTERVENTIONAL STUDY OF SAFETY, EFFICACY AND PHARMACOECONOMIC DATA FOR FINGOLIMOD PATIENTS IN DAILY CLINICAL PRACTICE

VALUE IN HEALTH

IF6

2015-11-019

OAAI

The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis

MULTIPLE SCLEROSIS JOURNAL

IF5

2012-05-2311

PREAI